Polymorphism at codon 31 of CDKN1A (p21) as a predictive factor for bevacizumabtherapy in glioblastoma multiforme

Polymorphism at Codon 31 of CDKN1A (p21) as a Predictive Factor for Bevacizumabtherapy in Glioblastoma Multiforme